NEALS Executive Committee Election Results
Please join us in congratulating James Berry from Mass General and Peggy Allred from Cedars-Sinai.
Trial News & Events
New therapy halts progression of Lou Gehrig’s disease in mice
Researchers at Oregon State University announced today that they have essentially stopped the progression of ALS, or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease. Read more here.…
Long Island PALS Accepted as Research Ambassador at Annual NEALS Conference
How Frank Verdone finds inspiration through educating people about the disease. Read more here.…
How One Man Brought the ALS Research Community Together
ALS patient Kevin Gosnell brought top doctors together, and now they're pledging to find a treatment in four years. Read more here.…
Update on ALS BrainStorm Stem Cell Clinical Trials
The new study showed that implanting stem cells that produce neurotrophic factors (MSC-NTF) into either muscle or the intrathecal space surrounding the spinal cord, or both, after 6 months were shown to be safe and associated with only mild and transient adverse effects, principally headache and fever. Read more here.…
PRO-ACT Database
We are excited to report that the PRO-ACT database is growing- Six new trials were added to the database, which now includes 23 trials and data from over 10,700 patients! The database is available for researchers on www.ALSDatabase.org …
2015 International Symposium on ALS/MND
Congratulations to NEALS Co-Chair Dr. Terry Heiman-Patterson for winning this year's prestigious Forbes Norris Award!
Gene and Stem Cell Therapies Make Strong Showing at ALS/MND Meeting
More than 800 researchers, clinicians, and patients with ALS gathered in balmy Orlando, Florida, on December 11-13, for the 26th International Symposium on ALS/MND. Read more here.…
Pauses and reversals ‘not uncommon’ in ALS progression
Patients with amyotrophic lateral sclerosis (ALS) often have periods of stable disease, with some even experiencing brief improvements, shows analysis of the PRO-ACT database. Read more here.…
MediciNova Announces Positive Interim Safety and Clinical Outcomes Data From Clinical Trial of MN-16
Presented at the 26th International Symposium on ALS/MND in Orlando, FL. Read more here.…